A history of poly A sequences: from formation to factors to function

Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3′ ends of eukaryotic mRNAs. Their presence in bacteria viruses and later in archeae (ref. 338) established their universality. The lack of compelling evidence fo...

Full description

Saved in:
Bibliographic Details
Published inProgress in Nucleic Acid Research and Molecular Biology Vol. 71; pp. 285 - 389
Main Author Edmonds, Mary
Format Book Chapter Journal Article
LanguageEnglish
Published United States Elsevier Science & Technology 2002
Subjects
Online AccessGet full text
ISBN9780125400718
0125400713
ISSN0079-6603
DOI10.1016/S0079-6603(02)71046-5

Cover

Abstract Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3′ ends of eukaryotic mRNAs. Their presence in bacteria viruses and later in archeae (ref. 338) established their universality. The lack of compelling evidence for a specific function limited attention to their cellular formation. Eventually the newer techniques of molecular biology and development of accurate nuclear processing extracts showed 3′ end formation to be a two-step process. Pre-mRNA was first cleaved endonucleolytically at a specific site that was followed by sequential addition of AMPs from ATP to the 3′ hydroxyl group at the end of mRNA. The site of cleavage was specified by a conserved hexanucleotide, AAUAAA, from 10 to 30 nt upstream of this 3′ end. Extensive purification of these two activities showed that more than 10 polypeptides were needed for mRNA 3′ end formation. Most of these were in complexes involved in the cleavage step. Two of the best characterized are CstF and CPSF, while two other remain partially purified but essential. Oddly, the specific proteins involved in phosphodiester bond hydrolysis have yet to be identified. The polyadenylation step occurs within the complex of poly A polymerase and poly A-binding protein, PABII, that controls poly A length. That the cleavage complex, CPSF, is also required for this step attests to a tight coupling of the two steps of 3′ and formation. The reaction reconstituted from these RNA-free purified factors correctly processes pre-mRNAs. Meaningful analysis of the role of poly A in mRNA metabolism or function was possible once quantities of these proteins most often over-expressed from cDNA clones became available. The large number needed for two simple reactions of an endonuclease, a polymerase and a sequence recognition factor, pointed to 3′ end formation as a regulated process. Polyadenylation itself had appeared to require regulation in cases where two poly A sites were alternatively processed to produce mRNA coding for two different proteins. The 64-KDa subunit of CstF is now known to be a regulator of poly A site choice between two sites in the immunoglobulin heavy chain of B cells. In resting cells the site used favors the mRNA for a membrane-bound protein. Upon differentiation to plasma cells, an upstream site is used the produce a secreted form of the heavy chain. Poly A site choice in the calcitonin pre-mRNA involves splicing factors at a pseudo splice site in an intron downstream of the active poly site that interacts with cleavage factors for most tissues. The molecular basis for choice of the alternate site in neuronal tissue is unknown. Proteins needed for mRNA 3′ end formation also participate in other RNA-processing reactions: cleavage factors bind to the C-terminal domain of RNA polymerase during transcription; splicing of 3′ terminal exons is stimulated by cleavage factors that bind to splicing factors at 3′ splice sites; nuclear export of mRNAs is linked to cleavage factors and requires the poly A II-binding protein. Most striking is the long-sought evidence for a role for poly A in translation in yeast where it provides the surface on which the poly A-binding protein assembles the factors needed for the initiation of translation. This adaptability of eukaryotic cells to use a sequence of low information content extends to bacteria where poly A serves as a site for assembly of an mRNA degradation complex in E. coli. Vaccinia virus creates mRNA poly A tails by a streamlined mechanism independent of cleavage that requires only two proteins that recognize unique poly A signals. Thus, in spite of 40 years of study of poly A sequences, this growing multiplicity of uses and even mechanisms of formation seem destined to continue.
AbstractList Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3' ends of eukarvotic mRNAs. Their presence in bacteria viruses and later in archeae (ref. 338) established their universality. The lack of compelling evidence for a specific function limited attention to their cellular formation. Eventually the newer techniques of molecular biology and development of accurate nuclear processing extracts showed 3' end formation to be a two-step process. Pre-mRNA was first cleaved endonucleolytically at a specific site that was followed by sequential addition of AMPs from ATP to the 3' hydroxyl group at the end of mRNA. The site of cleavage was specified by a conserved hexanucleotide, AAUAAA, from 10 to 30 nt upstream of this 3' end. Extensive purification of these two activities showed that more than 10 polypeptides were needed for mRNA 3' end formation. Most of these were in complexes involved in the cleavage step. Two of the best characterized are CstF and CPSF, while two other remain partially purified but essential. Oddly, the specific proteins involved in phosphodiester bond hydrolysis have yet to be identified. The polyadenylation step occurs within the complex of poly A polymerase and poly A-binding protein, PABII, that controls poly A length. That the cleavage complex, CPSF, is also required for this step attests to a tight coupling of the two steps of 3' and formation. The reaction reconstituted from these RNA-free purified factors correctly processes pre-mRNAs. Meaningful analysis of the role of poly A in mRNA metabolism or function was possible once quantities of these proteins most often over-expressed from cDNA clones became available. The large number needed for two simple reactions of an endonuclease, a polymerase and a sequence recognition factor, pointed to 3' end formation as a regulated process. Polyadenylation itself had appeared to require regulation in cases where two poly A sites were alternatively processed to produce mRNA coding for two different proteins. The 64-KDa subunit of CstF is now known to be a regulator of poly A site choice between two sites in the immunoglobulin heavy chain of B cells. In resting cells the site used favors the mRNA for a membrane-bound protein. Upon differentiation to plasma cells, an upstream site is used the produce a secreted form of the heavy chain. Poly A site choice in the calcitonin pre-mRNA involves splicing factors at a pseudo splice site in an intron downstream of the active poly site that interacts with cleavage factors for most tissues. The molecular basis for choice of the alternate site in neuronal tissue is unknown. Proteins needed for mRNA 3' end formation also participate in other RNA-processing reactions: cleavage factors bind to the C-terminal domain of RNA polymerase during transcription; splicing of 3' terminal exons is stimulated port of by cleavage factors that bind to splicing factors at 3' splice sites. nuclear ex mRNAs is linked to cleavage factors and requires the poly A II-binding protein. Most striking is the long-sought evidence for a role for poly A in translation in yeast where it provides the surface on which the poly A-binding protein assembles the factors needed for the initiation of translation. This adaptability of eukaryotic cells to use a sequence of low information content extends to bacteria where poly A serves as a site for assembly of an mRNA degradation complex in E. coli. Vaccinia virus creates mRNA poly A tails by a streamlined mechanism independent of cleavage that requires only two proteins that recognize unique poly A signals. Thus, in spite of 40 years of study of poly A sequences, this growing multiplicity of uses and even mechanisms of formation seem destined to continue.
Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3' ends of eukarvotic mRNAs. Their presence in bacteria viruses and later in archeae (ref. 338) established their universality. The lack of compelling evidence for a specific function limited attention to their cellular formation. Eventually the newer techniques of molecular biology and development of accurate nuclear processing extracts showed 3' end formation to be a two-step process. Pre-mRNA was first cleaved endonucleolytically at a specific site that was followed by sequential addition of AMPs from ATP to the 3' hydroxyl group at the end of mRNA. The site of cleavage was specified by a conserved hexanucleotide, AAUAAA, from 10 to 30 nt upstream of this 3' end. Extensive purification of these two activities showed that more than 10 polypeptides were needed for mRNA 3' end formation. Most of these were in complexes involved in the cleavage step. Two of the best characterized are CstF and CPSF, while two other remain partially purified but essential. Oddly, the specific proteins involved in phosphodiester bond hydrolysis have yet to be identified. The polyadenylation step occurs within the complex of poly A polymerase and poly A-binding protein, PABII, that controls poly A length. That the cleavage complex, CPSF, is also required for this step attests to a tight coupling of the two steps of 3' and formation. The reaction reconstituted from these RNA-free purified factors correctly processes pre-mRNAs. Meaningful analysis of the role of poly A in mRNA metabolism or function was possible once quantities of these proteins most often over-expressed from cDNA clones became available. The large number needed for two simple reactions of an endonuclease, a polymerase and a sequence recognition factor, pointed to 3' end formation as a regulated process. Polyadenylation itself had appeared to require regulation in cases where two poly A sites were alternatively processed to produce mRNA coding for two different proteins. The 64-KDa subunit of CstF is now known to be a regulator of poly A site choice between two sites in the immunoglobulin heavy chain of B cells. In resting cells the site used favors the mRNA for a membrane-bound protein. Upon differentiation to plasma cells, an upstream site is used the produce a secreted form of the heavy chain. Poly A site choice in the calcitonin pre-mRNA involves splicing factors at a pseudo splice site in an intron downstream of the active poly site that interacts with cleavage factors for most tissues. The molecular basis for choice of the alternate site in neuronal tissue is unknown. Proteins needed for mRNA 3' end formation also participate in other RNA-processing reactions: cleavage factors bind to the C-terminal domain of RNA polymerase during transcription; splicing of 3' terminal exons is stimulated port of by cleavage factors that bind to splicing factors at 3' splice sites. nuclear ex mRNAs is linked to cleavage factors and requires the poly A II-binding protein. Most striking is the long-sought evidence for a role for poly A in translation in yeast where it provides the surface on which the poly A-binding protein assembles the factors needed for the initiation of translation. This adaptability of eukaryotic cells to use a sequence of low information content extends to bacteria where poly A serves as a site for assembly of an mRNA degradation complex in E. coli. Vaccinia virus creates mRNA poly A tails by a streamlined mechanism independent of cleavage that requires only two proteins that recognize unique poly A signals. Thus, in spite of 40 years of study of poly A sequences, this growing multiplicity of uses and even mechanisms of formation seem destined to continue.Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3' ends of eukarvotic mRNAs. Their presence in bacteria viruses and later in archeae (ref. 338) established their universality. The lack of compelling evidence for a specific function limited attention to their cellular formation. Eventually the newer techniques of molecular biology and development of accurate nuclear processing extracts showed 3' end formation to be a two-step process. Pre-mRNA was first cleaved endonucleolytically at a specific site that was followed by sequential addition of AMPs from ATP to the 3' hydroxyl group at the end of mRNA. The site of cleavage was specified by a conserved hexanucleotide, AAUAAA, from 10 to 30 nt upstream of this 3' end. Extensive purification of these two activities showed that more than 10 polypeptides were needed for mRNA 3' end formation. Most of these were in complexes involved in the cleavage step. Two of the best characterized are CstF and CPSF, while two other remain partially purified but essential. Oddly, the specific proteins involved in phosphodiester bond hydrolysis have yet to be identified. The polyadenylation step occurs within the complex of poly A polymerase and poly A-binding protein, PABII, that controls poly A length. That the cleavage complex, CPSF, is also required for this step attests to a tight coupling of the two steps of 3' and formation. The reaction reconstituted from these RNA-free purified factors correctly processes pre-mRNAs. Meaningful analysis of the role of poly A in mRNA metabolism or function was possible once quantities of these proteins most often over-expressed from cDNA clones became available. The large number needed for two simple reactions of an endonuclease, a polymerase and a sequence recognition factor, pointed to 3' end formation as a regulated process. Polyadenylation itself had appeared to require regulation in cases where two poly A sites were alternatively processed to produce mRNA coding for two different proteins. The 64-KDa subunit of CstF is now known to be a regulator of poly A site choice between two sites in the immunoglobulin heavy chain of B cells. In resting cells the site used favors the mRNA for a membrane-bound protein. Upon differentiation to plasma cells, an upstream site is used the produce a secreted form of the heavy chain. Poly A site choice in the calcitonin pre-mRNA involves splicing factors at a pseudo splice site in an intron downstream of the active poly site that interacts with cleavage factors for most tissues. The molecular basis for choice of the alternate site in neuronal tissue is unknown. Proteins needed for mRNA 3' end formation also participate in other RNA-processing reactions: cleavage factors bind to the C-terminal domain of RNA polymerase during transcription; splicing of 3' terminal exons is stimulated port of by cleavage factors that bind to splicing factors at 3' splice sites. nuclear ex mRNAs is linked to cleavage factors and requires the poly A II-binding protein. Most striking is the long-sought evidence for a role for poly A in translation in yeast where it provides the surface on which the poly A-binding protein assembles the factors needed for the initiation of translation. This adaptability of eukaryotic cells to use a sequence of low information content extends to bacteria where poly A serves as a site for assembly of an mRNA degradation complex in E. coli. Vaccinia virus creates mRNA poly A tails by a streamlined mechanism independent of cleavage that requires only two proteins that recognize unique poly A signals. Thus, in spite of 40 years of study of poly A sequences, this growing multiplicity of uses and even mechanisms of formation seem destined to continue.
Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3' ends of eukaryotic mRNAs. Their presence in bacteria viruses and later in archeae (ref. 338) established their universality. The lack of compelling evidence for a specific function limited attention to their cellular formation. Eventually the newer techniques of molecular biology and development of accurate nuclear processing extracts showed 3' end formation to be a two-step process. Pre-mRNA was first cleaved endonucleolytically at a specific site that was followed by sequential addition of AMPs from ATP to the 3' hydroxyl group at the end of mRNA. The site of cleavage was specified by a conserved hexanucleotide, AAUAAA, from 10 to 30 nt upstream of this 3' end. Extensive purification of these two activities showed that more than 10 polypeptides were needed for mRNA 3' end formation. Most of these were in complexes involved in the cleavage step. Two of the best characterized are CstF and CPSF, while two other remain partially purified but essential. Oddly, the specific proteins involved in phosphodiester bond hydrolysis have yet to be identified. The polyadenylation step occurs within the complex of poly A polymerase and poly A-binding protein, PABII, that controls poly A length. That the cleavage complex, CPSF, is also required for this step attests to a tight coupling of the two steps of 3' and formation. The reaction reconstituted from these RNA-free purified factors correctly processes pre-mRNAs. Meaningful analysis of the role of poly A in mRNA metabolism or function was possible once quantities of these proteins most often over-expressed from cDNA clones became available. The large number needed for two simple reactions of an endonuclease, a polymerase and a sequence recognition factor, pointed to 3' end formation as a regulated process. Polyadenylation itself had appeared to require regulation in cases where two poly A sites were alternatively processed to produce mRNA coding for two different proteins. The 64-KDa subunit of CstF is now known to be a regulator of poly A site choice between two sites in the immunoglobulin heavy chain of B cells. In resting cells the site used favors the mRNA for a membrane-bound protein. Upon differentiation to plasma cells, an upstream site is used the produce a protein. Upon differentiation to Plasma cells, an upstream site is used the produce a secreted form of the heavy chain. Poly A site choice in the calcitonin pre-mRNA involves splicing factors at a pseudo splice site in an intron downstream of the active poly site that interacts with cleavage factors for most tissues. The molecular basis for choice of the alternate site in neuronal tissue is unknown. Proteins needed for mRNA 3' end formation also participate in other RNA-processing reactions: cleavage factors bind to the C-terminal domain of RNA polymerase during transcription; splicing of 3' terminal exons is stimulated by cleavage factors that bind to splicing factors at 3' splice sites; nuclear export of mRNAs is linked to cleavage factors and requires the poly A II-binding protein. Most striking is the long-sought evidence for a role for poly A in translation in yeast where it provides the surface on which the poly A-binding protein assembles the factors needed for the initiation of translation. This adaptability of eukaryotic cells to use a sequence of low information content extends to bacteria where poly A serves as a site for assembly of an mRNA degradation complex in E. coli. Vaccinia virus creates mRNA poly A tails by a streamlined mechanism independent of cleavage that requires only two proteins that recognize unique poly A signals. Thus, in spite of 40 years of study of poly A sequences, this growing multiplicity of uses and even mechanisms of formation seem destined to continue.
Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3′ ends of eukaryotic mRNAs. Their presence in bacteria viruses and later in archeae (ref. 338) established their universality. The lack of compelling evidence for a specific function limited attention to their cellular formation. Eventually the newer techniques of molecular biology and development of accurate nuclear processing extracts showed 3′ end formation to be a two-step process. Pre-mRNA was first cleaved endonucleolytically at a specific site that was followed by sequential addition of AMPs from ATP to the 3′ hydroxyl group at the end of mRNA. The site of cleavage was specified by a conserved hexanucleotide, AAUAAA, from 10 to 30 nt upstream of this 3′ end. Extensive purification of these two activities showed that more than 10 polypeptides were needed for mRNA 3′ end formation. Most of these were in complexes involved in the cleavage step. Two of the best characterized are CstF and CPSF, while two other remain partially purified but essential. Oddly, the specific proteins involved in phosphodiester bond hydrolysis have yet to be identified. The polyadenylation step occurs within the complex of poly A polymerase and poly A-binding protein, PABII, that controls poly A length. That the cleavage complex, CPSF, is also required for this step attests to a tight coupling of the two steps of 3′ and formation. The reaction reconstituted from these RNA-free purified factors correctly processes pre-mRNAs. Meaningful analysis of the role of poly A in mRNA metabolism or function was possible once quantities of these proteins most often over-expressed from cDNA clones became available. The large number needed for two simple reactions of an endonuclease, a polymerase and a sequence recognition factor, pointed to 3′ end formation as a regulated process. Polyadenylation itself had appeared to require regulation in cases where two poly A sites were alternatively processed to produce mRNA coding for two different proteins. The 64-KDa subunit of CstF is now known to be a regulator of poly A site choice between two sites in the immunoglobulin heavy chain of B cells. In resting cells the site used favors the mRNA for a membrane-bound protein. Upon differentiation to plasma cells, an upstream site is used the produce a secreted form of the heavy chain. Poly A site choice in the calcitonin pre-mRNA involves splicing factors at a pseudo splice site in an intron downstream of the active poly site that interacts with cleavage factors for most tissues. The molecular basis for choice of the alternate site in neuronal tissue is unknown. Proteins needed for mRNA 3′ end formation also participate in other RNA-processing reactions: cleavage factors bind to the C-terminal domain of RNA polymerase during transcription; splicing of 3′ terminal exons is stimulated by cleavage factors that bind to splicing factors at 3′ splice sites; nuclear export of mRNAs is linked to cleavage factors and requires the poly A II-binding protein. Most striking is the long-sought evidence for a role for poly A in translation in yeast where it provides the surface on which the poly A-binding protein assembles the factors needed for the initiation of translation. This adaptability of eukaryotic cells to use a sequence of low information content extends to bacteria where poly A serves as a site for assembly of an mRNA degradation complex in E. coli. Vaccinia virus creates mRNA poly A tails by a streamlined mechanism independent of cleavage that requires only two proteins that recognize unique poly A signals. Thus, in spite of 40 years of study of poly A sequences, this growing multiplicity of uses and even mechanisms of formation seem destined to continue.
Author Edmonds, Mary
Author_xml – sequence: 1
  givenname: Mary
  surname: Edmonds
  fullname: Edmonds, Mary
  organization: Department of Biological Sciences University of Pittsburgh Pittsburgh, Pennsylvania 15260, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/12102557$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtv1DAUhY0o0GmZnwDKCrWLwL3Xr5gNGrW8pEpdAGsrcWw1kMRTO1Np_j3JTGHBBm98bX3n6OqcM3YyxtEz9grhLQKqd98AtCmVAn4BdKkRhCrlE7Y2ugKoQBIphU-PbyQpZhyrE7b6K3vOVkIr0JxQn7J1zj9hPkSVQfWCnSIhkJR6xa43xV2Xp5j2RQzFNvb7YlNkf7_zo_P5fRFSHIoQ01BPXRyLKRahdjOeD-NudMv3S_Ys1H3268f7nP349PH71Zfy5vbz16vNTekF8Kk0FISARjpXk9SBWgoSpOFgaiU9YoMBhNNccRe4aFCoypMmjm1AMpL4OXtz9N2mOG-YJzt02fm-r0cfd9nOIRgujP4viEYKpWFxfP0I7prBt3abuqFOe_snoBmgf5x8E-Mv58cp1b27q7eTT9mSqagiq8QyzaIPR5Gfw3jofLLZdUugbZe8m2wbO4tgl6rtoWq7dGaB7KFqK_lvn4qUIA
ContentType Book Chapter
Journal Article
Copyright 2002
Copyright_xml – notice: 2002
DBID FFUUA
CGR
CUY
CVF
ECM
EIF
NPM
7TM
7U9
H94
7X8
DEWEY 572.8
DOI 10.1016/S0079-6603(02)71046-5
DatabaseName ProQuest Ebook Central - Book Chapters - Demo use only
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Nucleic Acids Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
AIDS and Cancer Research Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISBN 9780080522661
0080522661
Editor Moldave, Kivie
Editor_xml – sequence: 1
  fullname: Moldave, Kivie
EndPage 389
ExternalDocumentID 12102557
EBC298282_64_298
S0079660302710465
Genre Historical Article
Journal Article
Review
GroupedDBID --K
--Z
-~X
.55
.GJ
0R~
123
3O-
53G
5RE
85S
8N7
8NA
8NF
AAXUO
AAYSV
ABDPE
ABGWT
ABMAC
ABQQC
ABSWN
ACGFS
ACXMD
ADVLN
AFFNX
AFOST
AFTJW
AGAMA
AHDLI
AHMUE
AKRWK
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AZFZN
CS3
DU5
F5P
FDB
HZ~
H~9
JDP
MVM
O9-
SBF
SDK
SES
SHL
WH7
X7M
XOL
YNT
ZGI
ZKB
ZXP
089
20A
38.
A4I
A4J
AAAAS
AABBV
AALRI
AAORS
AAVWF
ALOFI
ALTAS
AZZ
BBABE
CZZ
FFUUA
HGY
MYL
SRW
CGR
CUY
CVF
ECM
EIF
NPM
VQA
7TM
7U9
ADXHL
H94
7X8
ID FETCH-LOGICAL-e403t-92f440b5cca257f2d2f5059309a65e11b1f04c7363cf34b1468e27231df129523
IEDL.DBID HGY
ISBN 9780125400718
0125400713
ISSN 0079-6603
IngestDate Fri Jul 11 01:18:45 EDT 2025
Thu Jul 10 23:21:23 EDT 2025
Wed Feb 19 01:33:24 EST 2025
Mon Sep 01 00:22:14 EDT 2025
Sun Apr 06 06:53:03 EDT 2025
IsPeerReviewed false
IsScholarly false
LCCallNum QP620.P76eb vol. 71
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-e403t-92f440b5cca257f2d2f5059309a65e11b1f04c7363cf34b1468e27231df129523
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Review-3
OCLC 476073217
PMID 12102557
PQID EBC298282_64_298
PQPubID 23462
PageCount 105
ParticipantIDs proquest_miscellaneous_71893497
proquest_miscellaneous_19546702
pubmed_primary_12102557
proquest_ebookcentralchapters_298282_64_298
elsevier_sciencedirect_doi_10_1016_S0079_6603_02_71046_5
PublicationCentury 2000
PublicationDate 2002
2002-00-00
20020101
PublicationDateYYYYMMDD 2002-01-01
PublicationDate_xml – year: 2002
  text: 2002
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Progress in Nucleic Acid Research and Molecular Biology
PublicationTitleAlternate Prog Nucleic Acid Res Mol Biol
PublicationYear 2002
Publisher Elsevier Science & Technology
Publisher_xml – name: Elsevier Science & Technology
SSID ssj0000228916
ssj0027906
Score 1.546542
SecondaryResourceType review_article
Snippet Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3′ ends of eukaryotic...
Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3' ends of eukarvotic...
Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3' ends of eukaryotic...
SourceID proquest
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 285
SubjectTerms Adenoviridae - genetics
Adenoviridae - metabolism
Escherichia coli
Escherichia coli - genetics
Escherichia coli - metabolism
History, 20th Century
Molecular biology
RNA Processing, Post-Transcriptional
RNA, Bacterial - genetics
RNA, Bacterial - metabolism
RNA, Fungal - genetics
RNA, Fungal - metabolism
RNA, Messenger - genetics
RNA, Messenger - history
RNA, Messenger - metabolism
RNA, Viral - genetics
RNA, Viral - metabolism
Saccharomyces cerevisiae - genetics
Saccharomyces cerevisiae - metabolism
Vaccinia virus
Vaccinia virus - genetics
Vaccinia virus - metabolism
Viral Proteins - genetics
Viral Proteins - metabolism
Title A history of poly A sequences: from formation to factors to function
URI https://dx.doi.org/10.1016/S0079-6603(02)71046-5
http://ebookcentral.proquest.com/lib/SITE_ID/reader.action?docID=298282&ppg=298&c=UERG
https://www.ncbi.nlm.nih.gov/pubmed/12102557
https://www.proquest.com/docview/19546702
https://www.proquest.com/docview/71893497
Volume 71
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3BTtwwEB3Bcqm4tIW2W1rqA0JUKMJx7DjubUVLV0X0UIEKJyvJ2tJKbbKC5bB_35lJsisOXHpLLFtWZuLxjD3vDcCRLCuLZl8l6cyaRFemSpwKZaJjWRP9l6kLAjhf_cynN_rHrbndgvMBC0Nplb3t72w6W-u-5ayX5tliPieMryVqSbp4o4tKsw07uHBzKmMw_X63Pmghghf2gYYozHHBTRqd0HDm2cEwieO1npJneC82mJ9uPh5xItVnnjIxT7aw51xU3qouXsIuwRcE4QpQZK9gKzSvYW_SYHD9dyWOBad88ln6HnydiI5veCXaKBbtn5WYiHVy9RdB2BOxhjeKZSv68jz8iDsiNe_DzcW36_Np0pdVSIKW2RJ1EbWWlUHd4XqNaqaiocJ-0pW5CWlapVHq2mZ5VsdMV4TNCsqiHziL6Bxg4PoGRk3bhHcgJDp_wUVZEEm9cqpMAzbMMmNrF2NdjKEYxOOfaNWjwfabBDOUrCfJeqk8S9abMZwO4vR8b9wnq9ad-B68chgsKp9rehrDp3VvXB906VE2oX188MRol1upnu-BanaZdnYMbzut-UVH9OGZXM0Y-_7_P-MAXnD9GD60-QCj5f1j-IhuzLI6hJ3J5a_fl4f8u_4DBsvlUw
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB0BPRRxoaXAlhZ8qKpWVYTj2HHc24qvpQVOINGTlWRtCalNVrAc9t93ZpIs4sCFW2LZsjITj2fseW8Avsiysmj2VZJOrUl0ZarEqVAmOpY10X-ZuiCA8-VVPrnRv27N7QocDVgYSqvsbX9n09la9y2HvTQPZ3d3hPG1RC1JF290UWlW4Y3GzZEI9Cdnf5YHLUTwwj7QEIU5LrhJoxMazjw7GCZxvNZT8gzvxRPmp5uPR3yT6jtPmZhnW9hLLipvVaebsEHwBUG4AhTZO1gJzXvYGjcYXP9biK-CUz75LH0Ljsei4xteiDaKWft3IcZimVz9UxD2RCzhjWLeir48Dz_ijkjNH-Dm9OT6aJL0ZRWSoGU2R11ErWVlUHe4XqOaqmiosJ90ZW5CmlZplLq2WZ7VMdMVYbOCsugHTiM6Bxi4bsNa0zZhF4RE5y-4KAsiqVdOlWnAhmlmbO1irIsRFIN4_DOtejTY_inBDCXrSbJeKs-S9WYEPwZxer437pNV6058D145DBaVzzU9jeBg2RvXB116lE1oHx88MdrlVqqXe6CaXaadHcFOpzU_64g-PJOrGWM_vv4zDuDt5Prywl-cX_3eg3WuJcMHOJ9gbX7_GD6jSzOv9vmX_Q_Nlual
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.title=Progress+in+Nucleic+Acid+Research+and+Molecular+Biology&rft.au=Edmonds%2C+Mary&rft.atitle=A+history+of+poly+A+sequences%3A+from+formation+to+factors+to+function&rft.date=2002-01-01&rft.pub=Elsevier+Science+%26+Technology&rft.isbn=9780125400718&rft.issn=0079-6603&rft.volume=71&rft.spage=285&rft.epage=389&rft_id=info:doi/10.1016%2FS0079-6603%2802%2971046-5&rft.externalDocID=S0079660302710465
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Febookcentral.proquest.com%2Fcovers%2F298282-l.jpg